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ABSTRACT
DNA instability is an important contributor to cancer development. Previously, 
defects in the chromosome segregation and excessive DNA double strand breaks due 
to the replication or oxidative stresses were implicated in DNA instability in cancer. 
Here, we demonstrate that DNA instability can directly result from the oncogene-
induced senescence signaling. Expression of the activated form of Her2 oncogene, 
NeuT, in immortalized breast epithelial cells led to downregulation of the major DNA 
repair factor histone H2AX and a number of other components of the HR and NHEJ 
double strand DNA breaks repair pathways. H2AX expression was regulated at the 
transcriptional level via a senescence pathway involving p21-mediated regulation 
of CDK and Rb1. The p21-dependent downregulation of H2AX was seen both in cell 
culture and the MMTV-neu mouse model of Her2-positive breast cancer. Importantly, 
downregulation of H2AX upon Her2/NeuT expression impaired repair of double 
strand DNA breaks. This impairment resulted in both increased DNA instability in 
the form of somatic copy number alterations, and in increased sensitivity to the 
chemotherapeutic drug doxorubicin. Overall, these findings indicate that the Her2/
NeuT oncogene signaling directly potentiates DNA instability and increases sensitivity 
to DNA damaging treatments.
INTRODUCTION
Most cancer cells are characterized by genomic 
instability manifested by aneuploidy with numerous 
karyotypic changes including whole chromosome gain 
and losses, translocations, deletions, amplifications, 
etc. According to current paradigm in the field, DNA 
instability is either the root cause of cancer or a critical 
contributor to cancer development. Genetic instability, i.e. 
aneuploidy, often results from abnormalities in mitosis 
[1], as well as abnormalities in the double strand break 
repair or telomere maintenance that can lead to repeated 
chromosome breakage–fusion–bridge cycles [2]. 
DNA instability (somatic copy number alterations, 
SCNA) is pervasive in tumors of different origin. Overall, 
it seems that genomic instability occurs early during 
tumorgenesis. For example, clonal populations within 
distant metastases from a pancreatic cancer were shown 
to be represented within the primary carcinoma, indicating 
that the genetic heterogeneity of metastases can exist 
before disseminating from the primary carcinoma [3]. 
Similarly, the degree of loss of heterozygosity (multiple 
deletions) in Her2-positive cancers [4] paralleled a 
substantial SCNA in early lesions, e.g. in breast lobular 
carcinoma in situ [5]. Interestingly, further progression 
towards cancer was not associated with higher instability. 
Indeed, amplifications and deletions in ductal carcinoma 
in situ (DCIS) were similar to those in neighboring tumors 
[6]. SCNAs in DCIS and invasive carcinoma also exhibit 
close similarity [7]. Therefore, most DNA instability in 
Her2-positive breast cancer arises in early lesions. The 
mechanisms of this instability may result from either 
oncogene activation or tumor suppressor inactivation. 
For example, expression of H-RasV12 or inactivation of 
PTEN or Rb1 induces chromosomal instability in various 
cell lines [8, 9]. Recently, we linked oncogene-induced 
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senescence (OIS) pathway with downregulation of the 
major DNA repair factor histone H2AX, and suggested 
that this pathway may be directly responsible for DNA 
instability in early lesions [10]. OIS represents an early 
barrier to neoplastic transformation [11-20], and therefore 
in order to become cancerous, cells acquire mutations 
or epigenetic changes that allow them to “turn off” the 
senescence program. 
We have recently demonstrated that the 
morphological and biochemical signs of senescence are 
not rigidly linked to permanent growth arrest. In fact, while 
activation of the oncogenes in epithelial cells with normal 
finite lifespan causes genuine senescence, activation 
of Her2/NeuT or Ras oncogenes in immortalized cells 
expressing endogenous telomerase triggers morphological 
and biochemical manifestations of senescence (e.g. SA-
β-gal), but does not ensure full growth arrest [10]. We 
called this condition Senescence With Incomplete Growth 
arrest (SWING). Importantly, SWING cells, despite their 
senescent appearance, are transformed and support tumor 
growth in xenographts [10]. Interestingly, in several types 
of mouse and human cancer proliferating cells in tumors 
simultaneously showed positive staining for SA-β-gal [19, 
21, 22]. Based on these data, we suggested that SWING 
could be an intermediate step in carcinogenesis in vivo. 
One of the major properties of cells in the SWING 
state induced by expression of the Her2 oncogene was 
downregulation of histone H2AX [10]. This findings lay 
the basis for a hypothesis that expression of an active 
Her2 oncogene results in suppression of the DNA repair 
systems, which drives genetic instability, and here, we test 
this hypothesis. 
RESULTS
Her2/NeuT oncogene causes downregulation of 
H2AX in a p21-dependent manner 
Previously we demonstrated that expression of 
NeuT in immortalized breast cancer epithelial cells 
MCF10A leads to significant downregulation of the 
major DNA repair factor histone H2AX. This effect 
required the upregulation of the senescence mediator 
p21 (1). Here we investigated if this pathway functions 
in vivo in the MMTV-neu mouse model of Her2-positive 
breast cancer. The age of tumor emergence in this 
strain of mice is approximately 12 month. Accordingly, 
12-month-old NeuT-expressing (MMTV-neu) mice and 
control FVB/NJ female mice were sacrificed, and levels 
of p21 and H2AX were assessed in isolated mammary 
tissue by immunohistochemistry with corresponding 
antibodies. Similar to cell culture experiments and in 
vivo observations in young (3 months old) mice (1), 
expression of NeuT caused significant up-regulation of 
p21 and simultaneously down-regulation of H2AX (Fig. 
1A, B). To address if Her2-mediated suppression of H2AX 
Fig.1: p21 knockout reverses downregulation of H2AX by NeuT expression. A. Expression of NeuT downregulates H2AX 
in 12 months old mice. Control and MMTVneu mice were sacrificed at the age of 12 months and expression of H2AX was assessed in 
mammary tissue by immunostaining. B. Knockout of p21 does not reduce NeuT expression in MMTVneu model. Mammary glands of 
12-months-old NeuT+/-p21+/+ and NeuT+/-p21-/- mice were immunostained for Her2/NeuT. C. p21 knockout restored expression of H2AX in 
NeuT+/- mice. Mammary glands of 12 months old NeuT+/-p21+/+ and NeuT+/-p21-/- mice were immunostained for H2AX.
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is p21-dependent in vivo we crossed NeuT-expressing 
(MMTV-neu) mice with p21 knockout mice to obtain a 
NeuT+/-p21-/- female litter. NeuT+/-p21+/+ females were used 
as a control (see Material and Methods). As seen on Fig. 
1C, both strains demonstrated strong expression of NeuT. 
Importantly, knockout of p21 reversed the downregulation 
of H2AX in NeuT-expressing mice (Fig. 1D). Therefore, 
the Her2-p21-H2AX pathway we previously identified in 
a breast cancer cell line is also functional in vivo in mouse 
mammary tissue. 
While the mechanism of upregulation of p21 
by Her2 in breast epithelial cells has been dissected 
previously, and involves the inflammatory loop and 
transcription factor Stat3 [23], the mechanism of H2AX 
downregulation by p21 remains unexplored. Therefore 
we next tested whether the changes in H2AX levels are 
caused by changes in protein degradation, translational 
efficiency, mRNA decay, or transcription. First, immortal 
human breast epithelial MCF10A cells were infected with 
control or Her2-expressing retrovirus, as in our prior 
publications (1), and Her2 expression was confirmed by 
immunoblotting (Fig. 2A). At day 5 post infection, after 
brief puromycin selection, the rate of degradation of 
H2AX in parental and MCF10A/Her2 cells was measured 
by immunoblotting following inhibition of translation by 
emetine. No significant degradation of H2AX either in 
control or NeuT-expressing cells was observed within six 
hours (Fig. 2B), indicating that the protein is relatively 
stable, thus eliminating the possibility that downregulation 
occurs via faster protein degradation. Next, to check if 
suppression of H2AX is due to less efficient translation, 
we used a 3’UTR Renilla/Luciferase double reporter 
(see Materials and Methods). In this reporter system 
Renilla is expressed under the control of 3’UTR of H2AX 
mRNA, while liciferase is extressed from the same 
plasmid without this 3’UTR, and serves as a standard 
for normalization. We observed minor translational 
suppression when H2AX 3’UTR was attached to the 
Renila gene; however, there was no difference in levels 
of the reporter luciferase/3’UTR between MCF10A and 
MCF10A/NeuT cells (Fig. 2C). Therefore, translation 
cannot explain downregulation of H2AX expression by 
Fig.2: NeuT oncogene suppresses expression of 
H2AX. A Expression of NeuT in MCF10A cells. MCF10A 
cells were infected with NeuT- expressing virus and two days 
post-infection selected with puromicin (0.75µg/ml). Control 
cells were infected with a corresponding empty virus. After 
6 days of selection, cells were harvested, lysed, and analyzed 
by immunoblotting. B. NeuT expression does not affect 
stability of H2AX. MCF10A cells were infected as above. 
Cells were treated with emetine (10µM) and levels of H2AX at 
corresponding time points were assayed by immunoblotting. C. 
NeuT expression doesn’t suppress translation of H2AX mRNA. 
MCF10A cells were infected as above. On day 6, post-infection 
cells were transfected with plasmid expressing renilla luciferase 
under H2AX 3’UTR control and the firefly luciferase used as an 
internal control. Translational efficiency was measured as renilla/
luciferase ration (relative units). D. NeuT oncogene suppresses 
transcription of H2AX mRNA. MCF10A cells were infected as 
above, and Q-PCR was performed as described in Materials and 
Methods to measure H2AX mRNA. Each sample was analyzed 
in triplicates. E. NeuT expression does not affect stability of 
H2AX mRNA. MCF10A cells were infected as above. Cells 
were treated with actinomycin D (7µg/ml) and samples for RNA 
extraction were collected at corresponding time points. Q-PCR 
was performed as described in Materials and Methods. Each 
point represents three independent experiments. F. Inhibition 
of CDKs suppresses expression of H2AX. MCF10A cells were 
treated with indicated doses of roscovitine overnight. Cells 
were lysed and H2AX levels were assayed by immunoblotting. 
G. Rb silencing reverses suppression of H2AX levels caused 
by expression of NeuT. MCF10A cells were simultaneously 
infected with NeuT- expressing retrovirus (under blasticidin 
selection) and siRB1-expressing lentivirus (under puromycin 
selection); control cells were infected with corresponding empty 
viruses. Two days post-infection puromycin (0.75µg/ml) and 
blastocidin (10µg/ml) were added and after another 7 days cells 
were harvested, lysed, and analyzed by immunoblotting to assay 
H2AX levels (left panel) or by Q-PCR to assay level of Rb1 
silencing (right panel).
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Her2. Next, we compared the levels of H2AX mRNA 
in parental and MCF10A/NeuT cells by RT-PCR. As 
seen in Fig. 2D, NeuT expression causes H2AX mRNA 
levels to reduce by about 50%. To understand whether 
the effect was due to lower transcription or higher mRNA 
degradation, we blocked transcription with actinomycin 
D and monitored levels of H2AX mRNA at different time 
points (Fig. 2E). In both MCF10A and MCF10A/NeuT 
cells, the rates of H2AX mRNA degradation were similar, 
indicating that Her2 does not affect the RNA degradation. 
Therefore regulation of H2AX expression by NeuT occurs 
at the transcription level.
The main mechanism by which p21 may inhibit 
the transcription of a specific gene involves inhibition 
of Rb phosphorylation by CDK4, 6. This subsequently 
inactivates the E2F family transcription factors [24]. 
To test whether this pathway is involved in H2AX 
regulation, we inhibited CDK proteins to see if this 
would mimic the effects of p21 on H2AX expression. 
Accordingly, MCF10A cells were treated with a broad-
specificity CDK inhibitor, roscovitine, and then levels 
of H2AX were monitored 15h later by immunoblotting. 
As seen in Fig. 2F, roscovitine treatment led to a dose-
dependent suppression of H2AX expression. We further 
tested if knockdown of Rb1 reverses the effects of Her2 
on H2AX downregulation. Using a lentivirus expressing 
Rb1-interfering shRNA that could be selected for using 
puromycin, we subcloned NeuT into a pCXbs retrovirus 
that was selected for using blastocidin. We titrated this 
virus to achieve levels of NeuT expression that were 
comparable with pBABE-based expression levels of 
Her2 and then verified that both viruses lead to similar 
(~70%) suppression of H2AX expression (data not 
shown). Next, MCF10A cells were simultaneously 
infected with lentivirus expressing shRb1 and retrovirus 
expressing NeuT. Corresponding ‘empty’ viruses were 
used as controls. As seen on Fig. 2G, 80% suppression of 
Rb1 almost completely reversed the effects of NeuT on 
H2AX downregulation, thus indicating that Rb1 is both 
necessary and sufficient for H2AX regulation. Therefore, 
transcriptional regulation of the DNA repair factor H2AX 
upon expression of the Her2/NeuT oncogene appears to 
involve the classical p21-CDK-Rb pathway.
We further investigated whether NeuT expression 
affects other components of the double strand DNA repair 
pathways, including the Homologous Recombination 
repair (HR) pathway and the Non-Homologous End 
Joining (NHEJ) pathway. Accordingly, we chose several 
major components of these pathways and tested their 
levels upon expression of NeuT by Q-PCR. Indeed, levels 
of components of the HR pathway, RPA1 and BRCA1, 
were significantly reduced in NeuT-expressing cells, while 
levels of BRCA2 and Rad51 remained almost unchanged. 
Similarly, levels of Ku70 and XRCC4 components of 
the NHEJ pathway declined upon NeuT transformation, 
while levels of Artemis, DNA PKCcs, and Ligase 4 did 
not change (Table 1). In addition, the levels of upstream 
sensor of double DNA breaks, MRE11a was also strongly 
suppressed. Therefore, it appears that expression of the 
Her2/NeuT oncogenes reduces expression of components 
of multiple DNA repair pathways. This may significantly 
jeopardize DNA repair and enhance DNA instability.
Her2/NeuT oncogene suppresses DNA repair
Upon exposure to genotoxic agents that cause 
double stranded DNA breaks, such as γ-irradiation, H2AX 
undergoes phosphorylation at Ser139. Phosphorylated 
H2AX (γH2AX) then recruits critical components of 
the DNA repair machinery leading to formation of 
‘irradiation foci’ at the sites of DNA damage. Accordingly, 
downregulation of H2AX and other components of the 
DNA repair pathways upon expression of Her2 may lead 
to defects in DNA repair. To test this possibility, NeuT-
transformed MCF10A cells were subjected to 5Gy gamma-
irradiation while the formation of foci by γH2AX and the 
quantities of two other important DNA repair factors, RPA 
and p53BP1 were monitored by immunoflourescence. The 
resolution of foci, reflecting completed DNA repair, was 
also monitored at different time points after irradiation. 
For all three repair factors, γH2AX, RPA and p53BP1, we 
observed significantly reduced foci formation at the initial 
2-hour time point (Fig. 3A, B). Interestingly, with γH2AX 
and RPA factors, we also observed slower foci resolution, 
which suggests suppressed DNA repair (Fig. 3C).
To investigate the effects of Her2 on the double 
Table1:
% suppression in 
Her2-expressing 
cells
H2AX 50% +/- 4%
Upstream sensor
MRE11a 40% +/- 5%                       
HR
BRCA1
BRCA2
Rad51
RPA
40% +/-3%
30% +/-6%
30% +/- 2%
65% +/- 4%
NHEJ
Ku70
XRCC4
Artemis
DNA PKcs
Lig 4
50% +/- 6%
40% +/-2.5%
0%
0%
0%
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strand DNA break repair by an independent method, 
we utilized a DR-GFP reporter system [25]. In this 
system, a GFP gene rendered un-functional by insertion 
of a recognition site for the I-SceI endonuclease can 
be repaired through homologous recombination using 
another non-functional GFP gene expressed from the same 
plasmid. As seen on Figs. 3D, E, expression of NeuT led 
to almost 75% reduction in the number of GFP positive 
cells, indicating that NeuT suppresses the HR DNA repair 
process. To test whether H2AX insufficiency is the sole 
cause of the reduced DNA repair capacity, we expressed 
H2AX in these cells using a lentiviral expression system 
(Fig. 3F). As seen in Fig. 3E, expression of H2AX 
significantly alleviated Her2-mediated suppression of 
Fig.3: Her2 expression hampers DNA Damage response. A-B. Formation of irradiation-induced foci is less efficient in MCF10A 
cells expressing Her2. MCF10A cells were infected as in Fig. 2 A. 6 days post selection, cells were 5Gy gamma irradiated, recovered for 
2 hours and processed for immunofluorecence as described in Materials and Method. Quantification of foci-positive cells (C) was done by 
observing 300 nuclei. Experiment was repeated twice. C. Foci resolution is slower in MCF10A cells expressing Her2. Cells were treated as 
above and recovered for indicated period of time. Number of foci-positive cells was calculated after counting 300 nuclei. Experiment was 
repeated twice. D-F. H2AX rescues Homologous Recombination (HR) impaired by Her2 expression. D. MCF10 cells stably expressing HR 
reporter plasmid, DR-GFP, were infected with Her2-expressing retrovirus along with H2AX-expressing lentivirus. After 6 day selection, 
cells were transfected with a plasmid encoding either GFP, as a positive control (left panel), Sce1 endonuclease that produces double 
stranded breaks (middle panel) or empty vector as a negative control (right panel); 24 hr. later HR was assayed by FACS to detect number 
of cells that reconstituted functional GFP (see Materials and Methods for details). E. Quantification of experimental data shown in panel 
D. F. Levels of H2AX in MCF10A cells stably expressing HR reporter, DR-GFP and Her2. MCF10A cells from Fig. 3 D, E were lysed and 
analyzed by immunoblotting. 
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HR. Therefore, H2AX appears to be the limiting factor 
in the DNA repair defects caused by Her2 expression. 
Overall, these independent experiments indicate that Her2 
expression leads to defects in the double strand breaks 
DNA repair, and that the defect is associated with H2AX 
downregulation. 
Her2/NeuT oncogene increases DNA instability
Cell’s reduced ability to repair double strand DNA 
breaks upon transformation with the Her2 oncogene may 
lead to DNA instability. To test this possibility directly, 
we characterized the level of spontaneous and induced 
DNA instability in Her2/NeuT-transfromed cells as 
compared to a parental control cells. Population of cells 
that persist in culture over long time periods may acquire 
DNA rearrangements and, thus, become genetically 
heterogeneous. To accurately assess the extent of DNA 
instability using SNP-arrays, we needed genetically 
homogenous populations, which were attained by growing 
clones of the MCF10A cells (Fig. 4A). Randomly selected 
clones were expanded, infected with retrovirus expressing 
NeuT (as in our prior experiments), and cloned again to 
yield three independent Her2/NeuT-transformed clones. 
We then used standard procedures to detect genomic 
amplifications and deletions (SCNA) by hybridization 
isolated genomic DNA to human SNP-arrays (See 
Methods and Materials). To characterize DNA instability, 
we normalized and segmented SNP-array data to detect 
individual alterations, their length and copy-number 
(Fig. 4B). We then identified a few SCNAs present in 
parental MCF10A cells that were probably acquired 
during immortalization (Fig. 4C). These parental SCNAs 
were removed from our analysis of DNA instability. We 
then used the total volume of all SCNAs, i.e. the sum 
of each SCNA’s copy-number change multiplied by 
its length, as an aggregate measure of DNA instability 
(SI). First, we note that NeuT-transformed cells did not 
show a significantly higher load of SCNAs than parental 
populations (Fig. 4C) eliminating the possibility that the 
Her2/NeuT oncogene transformation by itself causes 
significant spontaneous DNA instability.
Next, we tested whether Her2-transformed cells 
exhibit increased level of induced DNA instability by 
exposing both a parental MCF10A clone and one of the 
MCF10A/NeuT clones to low-dose (sub-therapeutic) 
doxorubicin, thereby introducing DNA damage. To 
accomplish this, cells were treated overnight with 10 
and 20nM of doxorubicin, then grown in normal media 
for 4 days and then cloned. DNA from these clones was 
isolated and hybridized on SNP-arrays. As seen on Fig. 
4C, treatment with either 10nM or 20nM of doxorubicin 
did not cause significant DNA instability in parental 
cells; however, even low 10nM doses of doxorubicin 
triggered significant DNA instability in Her2-expressing 
cells, while 20nM caused even stronger effects (Fig. 4C). 
Therefore, overall expression of the Her2 oncogene in 
breast epithelial cells reduces the expression of major 
DNA repair factors, which leads to reduced DNA repair 
capacity and enhanced DNA instability.
Fig.4: NeuT expression promotes DNA instability. (A) Scheme of the experiment. See the Results section for explanations. (B) 
SMNA in MCF10A cells according to the SNP analysis. Deletions and amplifications along the chromosomes 2, 11, 14 and 22 are shown 
as example. (C) Quantification of SNMA in control and NeuT-expressing cells treated with indicated doses of doxorubicin. (D) Sensitivity 
of control and NeuT-expressing MCF10A cells to doxorubicin. Clonogenic assay was performed, as described in Materials and Methods.
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In line with these results, we found that Her2-
transformed MCF10A cells were significantly more 
sensitive (determined by colony survival) to doxorubicin 
treatment than the parental untransformed MCF10A cells 
(Fig. 4D). Therefore, the overall expression of Her2/NeuT 
oncogene in breast epithelial cells reduces the expression 
of major DNA repair factors, and leads to a reduced ability 
to repair DNA and enhanced DNA instability, which in 
turn affect cells’ sensitivity to DNA-damaging treatments.
DISCUSSION
DNA instability is found in almost all human 
cancers. In some cancers, e.g. triple-negative breast 
cancer, DNA instability is an integral part of the process 
of tumorigenesis, and is driven by defects in DNA repair 
systems (e.g. mutations in BRCA1 or BRCA2), which 
result in further cancer-driving mutations. In other 
cancers, DNA instability results from defects in mitosis, 
which leads to large chromosomal rearrangements and 
aneuploidy. Yet, for the majority of cancers the origin of 
DNA instability is unclear. The major question in the field 
is whether DNA instability is the cause or the consequence 
of cancer. 
Here, we investigated the origin of DNA instability 
in the model of Her2-positive cancer, where no obvious 
link to defects in DNA repair systems has been reported. 
We built upon our prior data that expression of Her2/
NeuT oncogene in the breast epithelial cells MCF10A 
caused downregulation of the major DNA repair factor 
histone H2AX [10]. We then hypothesized that DNA 
instability in Her2-positive cancers results directly from 
the Her2 oncogene’s activity. Since Her2 is expressed 
in early lesions (i.e. ductal carcinoma in situ (DCIS)), 
our hypothesis predicts that these lesions should exhibit 
DNA instability. Indeed, in human cancer studies, DNA 
instability was reported in early lesions, as early as DCIS 
[26-28]. Moreover, our hypothesis predicts that instability 
results from defects in DNA repair (specifically p21 
mediated H2AX downregulation), and not from mitotic 
defects. In this study of DCIS lesions, DNA instability 
was monitored using the microsatellite instability assay. 
This assay should only detect focal SCNAs, and not 
than large chromosomal rearrangements [6]. Hence, it 
suggests that DNA instability in these lesions is indeed a 
result of improper DNA repair. Most convincingly, DNA 
instability in DCIS correlated with increased expression 
of Her2, upregulation of p21 and pleomorphic nuclei 
[29-31]. All these findings are highly consistent with 
our hypothesis that activation of Her2 upregulates p21, 
which downregulates histone H2AX, which induces DNA 
instability. 
The data reported here provided direct experimental 
prove that expression of the Her2 oncogene alone in 
immortalized breast epithelial cells is sufficient to cause 
defects in the HR DNA repair pathway. Interestingly, 
expression of Her2 causes significant downregulation 
of multiple DNA repair factors besides H2AX. These 
factors are involved in both HR and NHEJ DNA repair 
pathways, and include RPA1, BRCA1, Ku70, XRCC4 and 
MRE11a. Therefore, it is possible that both pathways of 
double strand DNA break repair are jeopardized in Her2-
expressing cells. Consistent with these findings, these 
cells had significantly increased vulnerability to genotoxic 
stress, as judged by a colony-forming assay. Suppression 
of DNA repair significantly increased DNA instability 
upon treatments with very low doses of doxorubicin. 
Indeed, incubation with 10 or 20nM doxirubicin created 
almost no SCNAs in control cells, yet many SCNAs in 
Her2-expressing cells. 
In our prior study, we linked downregulation of 
H2AX upon expression of Her2 to activation of senescence 
signaling (i.e. induction of p21) and progression to 
a SWING state [10]. This dependence was shown in 
cultured cells. Here, we demonstrated that this pathway 
functions in vivo in a mouse model of Her2-positive 
cancer. Indeed, expression of Her2 in the mammary tissue 
led to induction of p21 and downregulation of H2AX. 
Furthermore, downregulation of H2AX was effectively 
reversed by the p21 knockout.
Further question addressed in this study is how 
Her2 affects expression of H2AX. While the pathway that 
links Her2 and p21 has been established and involves the 
transcription factor Stat3, the downstream section of the 
pathway, i.e. how p21 regulates expression of H2AX, has 
not been known. Here, we demonstrated that the major 
p21-controlled Rb pathway is involved in this regulation. 
Indeed, depletion of Rb reversed the effects of Her2 
expression on H2AX levels. Furthermore, overexpression 
of Rb mimicked the effects of p21 expression on the 
levels of H2AX. Inhibition of CDKs had a similar effect, 
indicating that this regulation involves the p21-CDK-Rb 
pathway. Based on these findings, it is likely that this 
regulation also involves one or more of the eight E2F 
transcription factors.
Overall, this work describes a new mechanism of 
DNA instability in cancer. It demonstrates that senescence 
signaling, activated by Her2, leads to suppression of DNA 
repair pathways, increases DNA instability and increases 
vulnerability to genotoxic stresses. 
METHODS
Cell cultures, treatments, and reagents
HEK293 and MCF10A cells were obtained from the 
American Type Culture Collection. MCF10A/DR-GFP 
stable cell line was obtained by transfection of parental 
MCF10A cells using GeneCellin (BioCellChalange, 
Toulon Cedex9, France) with a DR-GFP reporter vector, 
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followed by 14 days of selection with puromycin. The 
DR-GFP reporter vector and plasmid expressing Sce1 
nuclease were a kind gift from Dr. Powell, Memorial 
Sloan Kettering Cancer Center, New York.
HEK293 cells were grown in DMEM supplemented 
with 10% fetal bovine serum; MCF10A cells were grown 
in DMEM⁄ F12 (1:1, v:v) containing 5% horse serum 
and supplemented with 10 µg/mL insulin, 20 ng/mL 
epidermal growth factor, 100ng/mL cholera toxin, 0.5 
µg/mL hydrocortisone, 100 units/ mL penicillin, and 0.1 
µg/mL streptomycin (10A complete media); MCF10A-
DR-GFP were grown in the same 10A complete media 
supplemented with puromycin (0.75 µg/mL). All cells 
were grown in a humidified environment at 370C with 5% 
CO2. 
Doxorubicin (Cat. #GR-319); puromycin (Cat. 
#GR-312), and roscovitine (Cat. #cc-205) were from 
BioMol (Plymouth Meeting, PA, USA); blasticidin was 
from InvivoGen (San Diego, CA; cat. #ant-bl-1); emetine 
(Cat. #E 2375) and actinomicin D (Cat. #A1410) were 
from Sigma (St. Louis, MO).
γ-IR spectroscopy of cells was performed using 
137Cs source (GammaCell 40) at 64 rad/min.
Recombinant retro- and lentiviral vectors
H2AX-expressing lentivirus and control ‘empty’ 
lentivirus were a kind gift from Dr. E. Brown (University 
of Pennsylvania Medical School, Philadelphia, PA); NeuT 
and control (pBABE) retroviral vectors were a kind gift 
from Dr. C. Spangenberg (Trost et al., 2005). This version 
of NeuT carries the activating V664E mutation (NeuT). 
Retrovirus expressing NeuT under blastocidine selection 
was obtained by subcloning NeuT from pBABE vector 
into pCXbsr retroviral vector. Cloning was done by 
Nahum Meller Custom DNA Constructs, 2340 Canterbury 
Rd, University Heights, OH, 44118. pCXbs was used as 
an ‘empty’ vector control. Lentivirus interfering with Rb1 
was a kind gift from Professor Jim Xia (Boston University, 
Boston, MA). 
Retro- and lentiviruses were produced as reported 
before [32, 33]. Briefly, HEK293T cells were co-
transfected with plasmids expressing retroviral proteins 
Gag-Pol, vesicular stomatitis virus glycoprotein 
pseudotype and enhanced green fluorescent protein or 
our constructs using Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA, USA). At 48 h after transfection, 
supernatants containing the retroviral particles were 
collected, aliquoted, and frozen at 800 C until use. Cells 
were infected with diluted supernatant in the presence 
of 10 µg/mL Polybrene overnight, and were selected 
with puromycin (0.75 µg/mL) or blasticidin (10µg/
mL) 48 h after infection. Retroviral vectors expressing 
enhanced green fluorescent protein was used as infection 
efficiency indicator: virus dilution was used to achieve 
approximately 90% of infected cells being GFP positive 
2 days after infection. Lentiviruses were produced in the 
same manner except for HEK293T transfections, where 
lentivirus-specific packaging plasmids psPAX2 and 
PMD2.G from Addgene were used. 
Immunoblotting
Cells lysates were prepared as described previously 
[32]. Antibodies used in the study were β-actin from 
Sigma; NeuT (Ser 1981) were a kind gift from Dr. T 
Kowalik (University of Massachusetts Medical Center, 
Worchester); γH2AX (Ser139) were from Millipore (Cat.# 
05-636; Billerica, MA, USA). Quantification of blots 
was performed using Quantity One software (Bio-Rad, 
Waltham, MA, USA). 
Immunohistochemistry
Mammary glands were excised from animals, spread 
on a Whatman filter strips, fixed in 4% formalin/PBS 
solution at 4o C for 48h upon which tissue was transferred 
to 70% ethanol. Samples were embedded into paraffin and 
processed into slides (5 µm in thickness). H2AX and p21 
staining was performed on these slides via standard ABC 
method (Vector Laboratory, Burlingame, CA, USA) using 
the following antibodies: p21Waf-1 Ab-9 (NeoMarkers, RB-
032-P1; 1:25); and H2AX (Proteintech Group # 10856-1-
AP; 1:100).
Immunofluorescence
After treatments, cells were fixed in 100% ice-
cold methanol/ acetone (50:50) at -200C for 10 min, then 
permeabilized in 0.2% Triton X-100 ⁄ PBS for 15 min at 
room temperature (RT), then blocked in 3% BSA ⁄ PBS for 
1 h, and then incubated with corresponding primary Ab 
at 4oC (γH2AX[Ser139](1:400); Cat. #05-636, Millipore, 
Billerica, MA, USA; 53BP1(1:50); BD Biosciences, 
RPA1(1:50); Calbiochem, Cat. #NA-18). Cells were 
washed out 3 times for 5 minutes each with 3% BSA ⁄ 
PBS followed by incubation with secondary Ab for 1 hour 
at RT. All antibody dilutions were made in Amplifying 
Antibody Dilution Buffer (ProHisto, Cat. #AA3; 
Columbia, SC). For RPA1 foci, cells were pre-extracted 
for 20 seconds with 0.2% Triton X-100 ⁄ PBS prior to 
fixation. Images were analyzed using Zeus fluorescent 
microscope (Carl Zeiss, Oberkochen, Germany).
Mouse breeding
All animals were ordered from Jackson laboratories. 
FVB/N-Tg(MMTVneu)202Mul/J [Neu+/+;p21+/+] (F) was 
crossed with B6129SF2/J B6;129S2-Cdkn1a<tm1Tyj>/J 
p21-/- (M); P1 females(Neu+/-; p21+/-) were back-crossed 
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with B6129SF2/J B6;129S2-Cdkn1a<tm1Tyj>/J p21-/- 
(M) and P2 females from the corresponding litter were 
genotyped (see below) to identify [Neu+/-; p21-/-] animals. 
Next, P2 (F) [Neu+/-; p21-/-] were back-crossed with 
B6129SF2/J B6;129S2-Cdkn1a<tm1Tyj>/J p21-/- (M); 
then the female litter was genotyped and [Neu+/-; p21-/-] 
animals were used in further experiments. In parallel a 
FVB/N-Tg(MMTVneu)202Mul/J [NeuT+/+;p21+/+] (F) 
was crossed with a p21WT parent M B6129SF2/J (M). 
The female litter [Neu+/-; p21+/+] was used as a control. 
FVB/NJ females were used as a control for FVB/N-
Tg(MMTVneu)202Mul/J mice. 
Animal maintenance and experiments were 
conducted in compliance with the guidelines of the 
Institutional Animal Care and Use Committee. 
Genotyping
 For genotyping, genomic DNA was purified from 
tails using Qiagen DNeasy Blood and Tissue kit (Cat. 
#69504; Valencia, CA). PCR to define p21 and NeuT 
status was performed according Jackson Laboratories 
recommendations.
Real Time PCR analysis
Total RNA was isolated from cells using Qiagen 
RNeasy Mini kit (Cat. #74104; Valencia, CA;). The 
RETROscript Kit (Ambion, Austin, TX, USA; Cat. 
#AM1710) was used to convert 2mg RNA into cDNA. 
qRT–PCR was performed using the SensiFast SYBR 
Green PCR kit (Bioline, Cat. # Bio-92020; London,UK;) 
according to the manufacture’s protocols; expression 
levels of GADPH were used as an internal control. Real-
time analysis was implemented with a Applied Biosystems 
S7300 instrument using the following primers:
H2AX: from Qiagen (Cat.#QT00233023; Valencia, 
CA) 
GAPDH:Forward: 5’ GAA GGT CGG AGT CAA 
CGG ATT T Reverse: 5’ ATG GGT GGA ATC ATA TTG 
GAA
Rb1: 
Forward: 5’CTCTCGTCAGGCTTGAGTTTG 
Reverse: 5’ GACATCTCATCTAGGTCAACTGC
BRCA1:
Forward: 5’ TCCCATCTGTCTGGAGTTGA 
Reverse: 5’ TGTGAAGGCCCTTTCTTCTG
BRCA2:
Forward: 5’ TGCCTGAAAACCAGATGACTATC 
Reverse: 5’ AGGCCAGCAAACTTCCGTTTA
MRE11a: 
Forward 5’ ATCGGCCTGTCCAGTTTGAAA 
Reverse 5’ TGCCATCTTGATAGTTCACCCAT
XRCC4: 
Forward: 5’ TGCAAAGAAATCTTGGGACAG 
Reverse: 5’ TGCTCCTTTTTCGACGTCTC
Ligase 4: 
Forward: 5’ AGCAAAAGTGGCTTATACGGATG 
Reverse: 5’ TGAGTCCTACAGAAGGATCATGC
Artemis: 
Forward: 5’ CCAAAGTACGGAGCCAAAGT 
Reverse: 5’ TTGGCAGAGGATCATCAAAG
DNA-PKcs: 
Forward: 5’ AGCTGGCTTGCGCCTATTT 
Reverse: 5’ GGGCACACCACTTTAACAAGAC
Ku70: 
Forward: 5’ GCTAGAAGACCTGTTGCGGAA 
Reverse: 5’ TGTTGAGCTTCAGCTTTAACCTG
RPA1: 
Forward: 5’ CCGTAGTAATGGGACGGATG 
Reverse: 5’ GCAGAAGGGGGATACAAACA
qPCR results are summarized as mean ± standard 
deviation.
Clonogenic assay 
Cells after treatments were counted using Scepter 
(Cat. #PHCC00000, Millipore, Billerica, MA, USA) and 
plated in triplicates on 100-mm Petri dishes. After 10 
days, the colonies were stained with 0.5% crystal violet 
in 70% ethanol and quantified. Survival was calculated 
as a percentage of colonies formed relative to untreated 
controls.
3’UTR translation assay
MCF10A cells were infected with “empty” or NeuT 
expressing retrovirus and selected with puromycin. On day 
6 post-infection, cells were transfected using GeneCellin 
(BioCellChalange) with psiCHECK2 (Promega) vector 
(1µg per well in 6-well plate) containing the 3’ UTR 
of H2AX cloned in the multiple cloning site of Renilla 
(kind gift from Dr. Chowdhury, Harvard Medical School.) 
After 24 h we measured renilla and luciferase activities 
using the Dual Luciferase Assay System (Promega) and 
the TopCount NXT microplate reader (Perkin Elmer), as 
per the manufacturer’s instructions. Data were normalized 
to Firefly luciferase. Each measurement was done in 
triplicates.
Measurement of HR activity with DR-GFP assay
HR activity was evaluated using the DR-GFP 
recombination substrate with a recognition site for the 
I-SceI endonuclease in one copy of the GFP gene. A 
gene conversion event within this substrate results in 
the expression of intact GFP protein [34]. Exponentially 
growing MCF10A/DR-GFP cells infected with 
corresponding viruses were transfected with a plasmid 
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expressing the I-SceI endonuclease or empty vector. After 
growth for an additional 24 h in fresh media, cells were 
harvested by trypsinization and re-suspended in PBS. 
Cells were analyzed for GFP expression by flowcytometry. 
FACS analysis
FACS analysis was performed on BD Biosciences 
(San Jose, CA, USA) FACSCalibur, and data were 
analyzed with BD FlowJo (Tree Star, Inc.;10.0.7 software.)
Assessment of Somatic Copy Number Alterations 
(SCNA)
DNA was isolated from individual clones and 
genotyped using Affymetrix Genome-wide Human SNP 
Array 6.0 (Cat. #901150) courtesy of the Broad Institute’s 
Genome Sequencing and Analysis Program. 
SNP probe intensities were quantified and DNA 
copy number was determined by segmenting SNP 
probes along the genome into tracks of equal copy 
number using the GLAD software package, an adaptive 
weights smoothing algorithm [35]. SCNAs were then 
identified from these tracks using a simplified calling 
rubric. Histograms of background-subtracted Log2 mean 
segment intensity were generated and then smoothed using 
a Gaussian kernel. Each sample’s histogram exhibited 
3-4 well-defined peaks, separated by approximately 
integer distances. Mean track intensities were scaled by a 
multiplicative constant such that the second peak, always 
the sample mode, was scaled to a ploidy value of 2.0 
(diploid). All track were then assigned ploidy by rounding 
their intensity to the nearest integer, baring one exception. 
If a track (1) contained only 1-2 probes, (2) was flanked 
on the left and right by tracks with the same ploidy, and 
(3) was within 1.0 intensity of its flanking assignment, 
the track was merged with its flanking assignments (e.g. 
a very short track with a scaled signal intensity of 3.72, 
and neighboring tracks assigned a ploidy of 3, would 
be merged with its neighboring tracks to forge one long 
SCNA of ploidy 3, rather than rounded to a ploidy of 
4. SCNA were then defined as uninterrupted tracks of 
ploidy other than diploid. We chose this method, rather an 
existing software package, because (i) our samples were 
clonal and did not need stromal rectifications, and (ii) we 
wanted an approach that did not bias towards specificity 
or sensitivity in calling SCNA, as we wanted to use these 
calls only to assess overall DNA instability.
Ancestral SCNA (existing in the cell lines prior 
to experimentation) were removed by identifying an 
ancestral genome. This ancestral genome was defined 
by SCNA that were shared (equal ploidy and ≥75% 
overlap) among all un-mutagenized (0 nM Dox) among 
all un-transformed (pBABE) MCF-10A clones. If a 
SCNA was shared (defined above) between a sample of 
interest and the ancestral genome, then it was excluded 
from our assessment of DNA instability. DNA instability 
was assessed by counting the total number of SCNA in a 
sample and by measuring their aggregate volume. Each 
SCNA individual volume was defined as its length (end 
location minus start location) multiplied by its amplitude 
(absolute difference from diploid). 
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